Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies

BioSeeker Group AB
March 19, 2013
5072 Pages - SKU: BIOS5014693
Cancer Vaccines: Technologies and Global Markets
1/1/2015 | published by: BCC Research
Cancer Vaccines: Technologies and Global Markets REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach  |  read more...
USD 6,650
Monoclonal Antibody Markets in China
12/1/2014 | published by: Asia Market Information & Development Company
Monoclonal Antibody Markets in China China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains  |  read more...
USD 4,000
Bispecific Antibody Therapeutics Market (2nd Edition), 2014-2024
12/2/2014 | published by: Roots Analysis
Bispecific Antibody Therapeutics Market (2nd Edition), 2014-2024 INTRODUCTION The concept of bispecific antibodies is increasingly gaining traction in the pharma industry owing to several therapeutic advantages and their potential to address challenges known  |  read more...
USD 1,899
Antibody Drugs: Technologies and Global Markets
1/1/2015 | published by: BCC Research
Antibody Drugs: Technologies and Global Markets The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2%  |  read more...
USD 6,650
Anti-CD22 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD22 Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD22 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD25 Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD25 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD274 (PD-L1) Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD279 (PD-1) Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD3 Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD3 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
Anti-CD38 Antibody -Pipeline Insights, 2014 SUMMARY DelveInsight’s,“Anti-CD38 Antibody-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the  |  read more...
USD 1,250
 

SELECT A LICENSE

    PDF E-mail From Publisher  USD 5,175  
    Global Site License Fulfilled by Publisher  USD 12,937.50  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!